INHIBITION OF VASOPRESSIN RELEASE IN MAN BY AN OPIATE PEPTIDE
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The opiate control of vasopressin secretion in man was investigated with a long-acting analogue of met-enkephalin, DAMME (FK33-824, Sandoz). Infusion of 1 mg DAMME into water-deprived volunteers produced a diuresis which was attenuated by naloxone; there was no change in water excretion when subjects were hydrated. Plasma-immunoreactive-vasopressin failed to rise after DAMME administration, despite osmotic stimulation with hypertonic saline infusion. Opiates appear to be involved in mechanisms which suppress the osmotically mediated release of vasopressin, while opiate involvement in baroceptor-mediated release may be quite different.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in this study, the effect of opioids on AVP seemed to be dependent on the hydration status, as DAMME infused into water-deprived healthy volunteers produced diuresis that was attenuated by naloxone, whereas when subjects were hydrated, there was no change in water excretion (177).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [177]
In the citing paper
“DAMME, a long-acting analogue of metenkephalin, produced water diuresis in dehydrated or in hypertonic saline-loaded subjects by inhibiting AVP release (177); in this study, the effect of opioids on AVP seemed to be dependent on the hydration status, as DAMME infused into water-deprived healthy volunteers produced diuresis that was attenuated by naloxone, whereas when subjects were hydrated, there”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [177]
Citations
Cites
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.
Chang, K. J., & Cuatrecasas, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30115-1 · Cited by 683
On the specificity of naloxone as an opiate antagonist
Sawynok, J., Pinsky, C., & LaBella, F. S. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90403-x · Cited by 614
A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity
ROEMER, D., BUESCHER, H. H., HILL, R. C., PLESS, J., BAUER, W., CARDINAUX, F., CLOSSE, A., HAUSER, D., & HUGUENIN, R. (1977) · Nature · doi:10.1038/268547a0 · Cited by 397
Hormonal and metabolic responses to an enkephalin analogue in normal man
Stubbs, W. A., Jones, A., Edwards, C. R. W., Delitala, G., Jeffcoate, W. J., Ratter, S. J., Besser, G. M., Bloom, S. R., & Alberti, K. G. M. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92100-1 · Cited by 353
Self-citationKOSTERLITZ, H. W., LORD, J. A. H., PATERSON, S. J., & WATERFIELD, A. A. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb10422.x · Cited by 315
Met-enkephalin circulates in human plasma
Clement-Jones, V., Lowry, P. J., Rees, L. H., & Besser, G. M. (1980) · Nature · doi:10.1038/283295a0 · Cited by 218
Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis
Iversen, L. L., Iversen, S. D., & Bloom, F. E. (1980) · Nature · doi:10.1038/284350a0 · Cited by 218
Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells
Kumakura, K., Karoum, F., Guidotti, A., & Costa, E. (1980) · Nature · doi:10.1038/283489a0 · Cited by 215
Effects of the synthetic enkephalin analogue FK 33-824 in man
VON GRAFFENRIED, B., DEL POZO, E., ROUBICEK, J., KREBS, E., PÖLDINGER, W., BURMEISTER, P., & KERP, L. (1978) · Nature · doi:10.1038/272729a0 · Cited by 160
Cited by
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Metadata
- Authors
- GROSSMAN, A.
- Affiliations
- St Bartholomew's Hospital (GB)
- Corresponding author
- GROSSMAN, A
- ORCID
- GROSSMAN, A
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1980-11
- Volume
- 316
- Issue
- 8204
- Pages
- 1108-1110
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2068823810
- Semantic Scholar
- 317fd804fca7a2cbca948dc0d194e9346dbd093e
- Cited by
- 88
- References
- 22
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2014: 1 · 2012: 1
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- vasopressin release, opioid peptides, Damme, naloxone, water deprivation, diuresis, osmotic stimulation, hypertonic saline, plasma vasopressin, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adolescent, Adult, Blood Pressure, Diuresis, Endorphins, Enkephalin, Methionine, D-Ala(2),MePhe(4),Met(0)-ol-enkephalin, Humans, Male, Osmolar Concentration, Osmosis, Saline Solution, Hypertonic, Secretory Rate, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: INHIBITION OF VASOPRESSIN RELEASE IN MAN BY AN OPIATE PEPTIDE. https://app.cochat.ai/papers/10.1016/s0140-6736(80)92542-8
- The paper
- GROSSMAN, A. (1980). INHIBITION OF VASOPRESSIN RELEASE IN MAN BY AN OPIATE PEPTIDE. The Lancet. https://doi.org/10.1016/s0140-6736(80)92542-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.